Listed APIs & intermediates makers · GMP-regulated QC data flow
Listed manufacturers of pharmaceutical and specialty-chemical intermediates and APIs need a compliant data flow from chromatography PDFs into LIMS under NMPA's data-integrity rules. This is the typical deployment scenario for that profile.
About this page: this is a deployment scenario for a typical customer profile — not the specific numbers of any one customer. Figures below come from internal testing and early-deployment observations; they do not represent any particular customer’s actuals.
Customer profile
Listed (main board or SME board) manufacturers of pharmaceutical, agrochemical, and functional-chemical intermediates and APIs — many serving multinational pharma clients. Customers in this profile typically:
- Carry multiple multinational pharma orders concurrently, with data-integrity expectations aligned to FDA / EMA inspection norms
- Run QC labs primarily on Waters Empower and Thermo Chromeleon
- Must align to NMPA’s “Drug Records and Data Management Requirements” with GMP-retained audit logs
Pain points
- No traceable link from values to PDFs: manual entry leaves no machine-readable pointer between recorded values and source PDF
- Heavy two-person review: every report requires two independent transcriptions plus item-by-item reconciliation
- Data-integrity upgrade pressure: legacy workflows struggle under updated ALCOA+ expectations
ChromaParse deployment pattern
- Plan: Local Pro
- Coverage: Waters Empower, Thermo Chromeleon
- Compliance: Aligned to ALCOA+; audit logs retained per GMP
- Private library: Several internal report templates
Value and expected outcomes
Figures below come from internal testing and early-deployment observation; actual gains depend on report complexity:
- Two-person review effort materially reduced
- Full data-integrity audit-trail coverage; an auditable pointer chain links every value back to its source PDF
- Historical PDF reports can be bulk structured-imported into LIMS as part of a digitisation effort
Other scenarios
Small-molecule CDMOs serving multinational pharma run Empower and OpenLab side by side; QC teams process hundreds of chromatography PDFs every day. This is the typical deployment scenario for that profile.
Shanghai-listed injectables and oral-formulations manufacturers need to migrate historical PDF reports into a next-generation LIMS compliantly. This is the typical deployment scenario for that profile.
Listed specialty-API CDMOs run four different chromatograph vendors across plants — cross-site data normalisation is the core pain. This is the typical deployment scenario for that profile.
Want to be the next adopter?
Get in touch with sales — we'll scope a deployment for your environment.